DocuSign plans to cut 6% of its work force
By Steve Gelsi
Tech layoffs continue as DocuSign reduces head count by about 400 people
DocuSign Inc. said Tuesday it will take up to $32 million in charges against its earnings as part of a cost-cutting move to reduce its work force by 6%, as job reductions continue in the technology sector.
DocuSign's stock (DOCU) fell 2% at the closing bell on Tuesday after it warned it will take restructuring charges of $28 million to $32 million for the move, mostly in first quarter of fiscal 2025.
The stock is down by 12.2% so far in 2024, compared to a 3.9% gain by the S&P 500 SPX.
The company will share further financial details about the restructuring during its fourth-quarter fiscal 2024 results on March 8.
The cost-cutting move will affect about 400 people, according to a blog post by Chief Executive Allan Thygesen.
DocuSign said the majority of the job cuts are in its sales and marketing unit.
The job cuts will help "strengthen and support the company's financial and operational efficiency," the company said.
It's the latest in a series of cost-cutting moves in the U.S. work force, particularly in the software business.
Microsoft Corp. (MSFT) recently cut 1,900 jobs as part of layoffs in the video game industry. Unity Software Inc. (U) is reducing its work force by 25% or about 1,800 people.
Also read: Tech layoffs in the spotlight again as 2024 kicks off with Xerox job cuts
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-06-24 1629ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks